Skip to main content

Table 3 clinical outcomes of two classes

From: Physiological and clinical variables identify ARDS classes and therapeutic heterogeneity to glucocorticoids: a retrospective study

Clinical Outcome

Class1 (n = 866)

Class2 (n = 238)

P-value

Mortality (Los), n (%)

120(13.9%)

65(27.3%)

< 0.001

Mortality (28-day), n (%)

112(12.9%)

60(25.2%)

< 0.001

ICU LOS, median (25–75%)

9(5–15)

13(9–19)

< 0.001

Hospital LOS, median (25–75%)

15(9–23)

19(11–28)

< 0.001

Ventilator-Free Days, median (25–75%)

26(23–27)

24(20–26)

< 0.001

  1. Ventilator-free days observation until 28 days